🍽️ tiletamine hydrochloride,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Anesthesia: Tiletamine hydrochloride is used for general anesthesia in animals, particularly in cats and non-human primates. It produces a rapid onset of anesthesia and maintains anesthesia for a relatively short duration, making it suitable for procedures of varying lengths.

  2. Analgesia: Tiletamine hydrochloride provides analgesia (pain relief) along with anesthesia, which can be beneficial for surgical procedures that may cause pain or discomfort.

  3. Sedation: Tiletamine hydrochloride can also be used for sedation in veterinary medicine. It produces a calming effect and may be administered to facilitate handling, restraint, or minor procedures in animals.

  4. Muscle Relaxation: Tiletamine hydrochloride has muscle relaxant properties, which can be advantageous during surgical procedures by reducing muscle tone and preventing involuntary movements.

  5. Rapid Onset and Recovery: One of the advantages of tiletamine hydrochloride is its rapid onset of action, allowing for quick induction of anesthesia or sedation. Additionally, animals typically recover from anesthesia relatively quickly after discontinuation of tiletamine administration.

  6. Combination Therapy: Tiletamine hydrochloride is often combined with zolazepam, a benzodiazepine derivative, to form a combination drug known as Zoletil or Telazol. This combination enhances the anesthetic effects and provides balanced anesthesia, combining the sedative and muscle relaxant properties of both drugs.

  7. Respiratory Depression: Tiletamine hydrochloride, like other anesthetic agents, can cause respiratory depression in animals. Careful monitoring of respiratory rate and effort is essential during anesthesia to prevent respiratory complications.

  8. Cardiovascular Effects: Tiletamine hydrochloride may have cardiovascular effects, including alterations in heart rate and blood pressure. Monitoring of cardiac function is recommended during anesthesia, especially in animals with pre-existing cardiovascular conditions.

  9. Recovery Considerations: After administration of tiletamine hydrochloride, animals may experience disorientation, ataxia (loss of coordination), and muscle tremors during the recovery period. Providing a quiet and safe environment for recovery is important to minimize stress and prevent injury.

  10. Safety and Handling: Tiletamine hydrochloride is a potent anesthetic agent and should be handled with care to prevent accidental exposure or ingestion. Proper storage and disposal procedures should be followed to ensure safety.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of tiletamine hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by tiletamine hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Eggerthella genus Decreases 👪 Source Study
Lachnospira genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Lacrimispora genus Decreases 👪 Source Study
Bilophila genus Decreases 👪 Source Study High Level Cause Brain Fog(Cognitive impairment)
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Eggerthella lenta species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Lachnospira eligens species Decreases 📓 Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Roseburia intestinalis species Decreases 📓 Source Study
Lacrimispora saccharolytica species Decreases 📓 Source Study
Bilophila wadsworthia species Decreases 📓 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of tiletamine hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0 0
ADHD 0 0.2 0
Age-Related Macular Degeneration and Glaucoma 0 0 0
Allergic Rhinitis (Hay Fever) 0 0
Allergies 0.2 0.2
Allergy to milk products 0 0
Alopecia (Hair Loss) 0 0
Alzheimer's disease 0 0.1 0
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.1 0.1
Ankylosing spondylitis 0.1 0.1 0
Anorexia Nervosa 0 0.1 0
Antiphospholipid syndrome (APS) 0.1 0 0
Asthma 0.4 0 0
Atherosclerosis 0.1 -0.1
Atrial fibrillation 0.1 0 0
Autism 0.5 0.3 0.67
Barrett esophagus cancer 0 0
Bipolar Disorder 0 0.2 0
Brain Trauma 0 0
Carcinoma 0.3 0 0
Celiac Disease 0 0.1 0
Cerebral Palsy 0 0 0
Chronic Fatigue Syndrome 0.7 0.1 6
Chronic Kidney Disease 0.2 0.1 1
Chronic Lyme 0 0
Chronic Obstructive Pulmonary Disease (COPD) 0.1 0.1 0
Chronic Urticaria (Hives) 0 0
Coagulation / Micro clot triggering bacteria 0.1 0.1 0
Colorectal Cancer 0.1 0.1
Constipation 0.1 0 0
COVID-19 0.6 0.6 0
Crohn's Disease 0.3 0.3 0
cystic fibrosis 0 0
deep vein thrombosis 0.1 -0.1
Depression 1.1 0.1 10
Dermatomyositis 0 0
Eczema 0.1 -0.1
Endometriosis 0.1 0.1 0
Epilepsy 0 0 0
Fibromyalgia 0 0
Functional constipation / chronic idiopathic constipation 0.2 0 0
gallstone disease (gsd) 0 0 0
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0 0
Glioblastoma 0 0
Graves' disease 0 0 0
Halitosis 0 0
Hashimoto's thyroiditis 0 0 0
Hidradenitis Suppurativa 0.1 0.1
Histamine Issues 0.1 0.1
hyperglycemia 0 0
hypersomnia 0 0
hypertension (High Blood Pressure 0.1 0.1 0
Hypothyroidism 0.2 -0.2
Hypoxia 0 0
IgA nephropathy (IgAN) 0.1 -0.1
Inflammatory Bowel Disease 0.3 0.2 0.5
Insomnia 0 0.1 0
Intracranial aneurysms 0 0
Irritable Bowel Syndrome 0 0.1 0
Liver Cirrhosis 0.1 0.1 0
Long COVID 0.3 0.3 0
Low bone mineral density 0.1 -0.1
Mast Cell Issues / mastitis 0 0
ME/CFS with IBS 0 0
ME/CFS without IBS 0.7 0 0
Metabolic Syndrome 0.3 0.1 2
Mood Disorders 1.1 0.3 2.67
multiple chemical sensitivity [MCS] 0.1 0.1
Multiple Sclerosis 0.7 0.3 1.33
neuropathic pain 0.1 -0.1
Neuropathy (all types) 0 0
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0 0.1 0
Obesity 0.1 0.1 0
obsessive-compulsive disorder 0.1 0.1
Osteoarthritis 0 0
Osteoporosis 0.2 0.2
pancreatic cancer 0 0
Parkinson's Disease 0.3 0.2 0.5
Polycystic ovary syndrome 0 0 0
Premenstrual dysphoric disorder 0 0
Psoriasis 0 0.1 0
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.4 0 0
Rosacea 0 0
Schizophrenia 0.3 0 0
scoliosis 0.2 -0.2
Sjögren syndrome 0.1 0 0
Sleep Apnea 0.2 -0.2
Small Intestinal Bacterial Overgrowth (SIBO) 0 0
Stress / posttraumatic stress disorder 0 0.4 0
Systemic Lupus Erythematosus 0.3 0.1 2
Type 1 Diabetes 0 0.1 0
Type 2 Diabetes 0.3 0.1 2
Ulcerative colitis 0 0.1 0
Unhealthy Ageing 0.2 0 0

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant or equivalent EU laws. [34.239.170 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [34.239.170 ]